XML 20 R19.htm IDEA: XBRL DOCUMENT
v3.19.3

Stockholders' Deficit | 9 Months Ended
--- | ---
Sep. 30, 2019
Compensation Related Costs [Abstract] |
Stockholders' Deficit | Stockholders’ Deficit Changes in Stockholders’ Deficit The following tables present certain information regarding our stockholders’ deficit as of September 30, 2019 and September 30, 2018:
| Common Stock |  | Additional Paid in Capital |  | Accumulated Loss |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interest |  | Total
January 1, 2019 | $ | 1 |  |  | $ | 835 |  |  | $ | (2,824 | ) |  | $ | (175 | ) |  | $ | (300 | ) |  | $ | — |  |  | $ | (2,463 | )
Net proceeds of common stock in connection with stock options and RSUs | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2 |
Stock-based compensation | — |  |  | 11 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 11 |
Net loss | — |  |  | — |  |  | (24 | ) |  | — |  |  | — |  |  | — |  |  | (24 | )
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 51 |  |  | — |  |  | 51 |
March 31, 2019 | $ | 1 |  |  | $ | 848 |  |  | $ | (2,848 | ) |  | $ | (175 | ) |  | $ | (249 | ) |  | $ | — |  |  | $ | (2,423 | )
Net proceeds of common stock in connection with stock options and RSUs and other | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2 |
Sale of SciPlay common stock and related transactions | — |  |  | 328 |  |  | — |  |  | — |  |  | — |  |  | 91 |  |  | 419 |
Stock-based compensation | — |  |  | 9 |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | 10 |
Net loss | — |  |  | — |  |  | (77 | ) |  | — |  |  | — |  |  | 2 |  |  | (75 | )
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (51 | ) |  | — |  |  | (51 | )
June 30, 2019 | $ | 1 |  |  | $ | 1,187 |  |  | $ | (2,925 | ) |  | $ | (175 | ) |  | $ | (300 | ) |  | $ | 94 |  |  | $ | (2,118 | )
Net proceeds of common stock in connection with stock options, RSUs and other | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |
Stock-based compensation | — |  |  | 9 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 9 |
Net income | — |  |  | — |  |  | 14 |  |  | — |  |  | — |  |  | 4 |  |  | 18 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (35 | ) |  | — |  |  | (35 | )
September 30, 2019 | $ | 1 |  |  | $ | 1,197 |  |  | $ | (2,911 | ) |  | $ | (175 | ) |  | $ | (335 | ) |  | $ | 98 |  |  | $ | (2,125 | )
| Common Stock |  | Additional Paid in Capital |  | Accumulated Loss |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Total
January 1, 2018 | $ | 1 |  |  | $ | 808 |  |  | $ | (2,461 | ) |  | $ | (175 | ) |  | $ | (200 | ) |  | $ | (2,027 | )
Net proceeds of common stock in connection with stock options and RSUs | — |  |  | (15 | ) |  | — |  |  | — |  |  | — |  |  | (15 | )
Stock-based compensation | — |  |  | 7 |  |  | — |  |  | — |  |  | — |  |  | 7 |
Net loss | — |  |  | — |  |  | (202 | ) |  | — |  |  | — |  |  | (202 | )
Adoption impact of ASC 606 | — |  |  | — |  |  | (11 | ) |  | — |  |  | — |  |  | (11 | )
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 52 |  |  | 52 |
March 31, 2018 | $ | 1 |  |  | $ | 800 |  |  | $ | (2,674 | ) |  | $ | (175 | ) |  | $ | (148 | ) |  | $ | (2,196 | )
Net proceeds of common stock in connection with stock options and RSUs | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | 2 |
Stock-based compensation | — |  |  | 15 |  |  | — |  |  | — |  |  | — |  |  | 15 |
Net loss | — |  |  | — |  |  | (6 | ) |  | — |  |  | — |  |  | (6 | )
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (83 | ) |  | (83 | )
June 30, 2018 | $ | 1 |  |  | $ | 817 |  |  | $ | (2,680 | ) |  | $ | (175 | ) |  | $ | (231 | ) |  | $ | (2,268 | )
Net proceeds of common stock in connection with stock options and RSUs | — |  |  | (3 | ) |  | — |  |  | — |  |  | — |  |  | (3 | )
Stock-based compensation | — |  |  | 9 |  |  | — |  |  | — |  |  | — |  |  | 9 |
Net loss | — |  |  | — |  |  | (352 | ) |  | — |  |  | — |  |  | (352 | )
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (5 | ) |  | (5 | )
September 30, 2018 | $ | 1 |  |  | $ | 823 |  |  | $ | (3,032 | ) |  | $ | (175 | ) |  | $ | (236 | ) |  | $ | (2,619 | )
SciPlay Stock Based Compensation During the second quarter of 2019, SciPlay adopted the SciPlay Long-Term Incentive Plan (“SciPlay LTIP”). The SciPlay LTIP authorizes the issuance of up to 6.5 million shares of SciPlay’s Class A common stock to be granted in connection with awards of incentive and nonqualified stock options, restricted stock and stock units, stock appreciation rights and performance-based awards. As of September 30, 2019, there were 4.0 million of total time-based and performance-based SciPlay restricted stock units issued with an average grant price of $15.30 per share. The following reflects total stock-based compensation expense recognized under all programs:
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Related to SGC stock options | $ | 1 |  |  | $ | 3 |  |  | $ | 4 |  |  | $ | 11 |
Related to SGC RSUs | 6 |  |  | 7 |  |  | 23 |  |  | 23 |
Related to SciPlay RSUs | 2 |  |  | — |  |  | 6 |  |  | — |
Total | $ | 9 |  |  | $ | 10 |  |  | $ | 33 |  |  | $ | 34 |

X
- References No definition available. + Details
Name: | us-gaap_CompensationRelatedCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for compensation costs, including compensated absences accruals, compensated absences liability, deferred compensation arrangements and income statement compensation items. Deferred compensation arrangements may include a description of an arrangement with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares (units) issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -URI http://asc.fasb.org/topic&trid=2127225 + Details
Name: | us-gaap_CompensationRelatedCostsGeneralTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration